Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02GTN
|
|||
Former ID |
DIB009209
|
|||
Drug Name |
ZY-15106
|
|||
Synonyms |
MgNAAGA; NAAGAMg; Rhinaaxia; N-Acetylaspartyl-glutamic acid magnesium salt
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Asthma [ICD-11: CA23; ICD-10: J45, J45.8; ICD-9: 493] | Phase 2 | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C11H16N2O8
|
|||
Canonical SMILES |
CC(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)O
|
|||
InChI |
1S/C11H16N2O8/c1-5(14)12-7(4-9(17)18)10(19)13-6(11(20)21)2-3-8(15)16/h6-7H,2-4H2,1H3,(H,12,14)(H,13,19)(H,15,16)(H,17,18)(H,20,21)/t6-,7+/m0/s1
|
|||
InChIKey |
OPVPGKGADVGKTG-NKWVEPMBSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR. Neuropharmacology. 2009 May-Jun;56(6-7):1060-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.